Keytruda wins FDA nod
for treating Kidney Cancer
Merck’s Keytruda has recently got the U.S. FDA approval to be administered for Kidney Cancer. The drug Keytruda was approved in combination with Pfizer’s Inlyta for the treatment of advanced renal carcinoma. This therapy could prove to be serious for competition Bristol-Myers Squibb’s immunotherapy combination of Opdivo and Yervoy.
Naloxone can reverse Opioid
overdose
The U.S. FDA has recently approved Naloxone also known as Narcan- the first generic nasal spray to treat Opioid overdose. Narcan, developed by Israel’s Teva Pharmaceuticals, is a pre-filled, needle-free device which is sprayed into the nostrils of...
